At baseline, when participants had not yet started to take PrEP, the score for “worries about drug side effects” was 2.97 ± 1.15, but it showed a decreasing trend during the follow-up.
← all excerpts
Associations between perceived barriers and benefits of using HIV pre-exposure prophylaxis and medication adherence among men who have sex with men in Western China.
2
—
—
The sentences
Participants had a relatively high expectation about the efficacy of the drugs at baseline (3.17 ± 1.36), and even though the score was 2.89 ± 1.41 at first follow-up, there was an increasing trend throughout the follow-up, which reached 3.72 ± 1.37 at the end.